A Multicenter, Randomized, Double-blind, Placebo-controlled Parallel-group Phase 2 Clinical Trial to Evaluate the Efficacy and Safety of XH-S004 Tablets in Patients With Non-cystic Fibrosis Bronchiectasis
Latest Information Update: 28 May 2025
At a glance
- Drugs XH S004 (Primary)
- Indications Bronchiectasis
- Focus Therapeutic Use
- Sponsors S-Infinity Pharmaceuticals
Most Recent Events
- 28 May 2025 New trial record